Compare SWKH & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SWKH | INFU |
|---|---|---|
| Founded | 1996 | 2005 |
| Country | United States | United States |
| Employees | 9 | N/A |
| Industry | Diversified Financial Services | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 198.4M | 208.8M |
| IPO Year | N/A | 2005 |
| Metric | SWKH | INFU |
|---|---|---|
| Price | $15.90 | $9.14 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $18.00 | $15.00 |
| AVG Volume (30 Days) | 104.8K | ★ 168.6K |
| Earning Date | 05-14-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.05 |
| Revenue | N/A | ★ $143,436,000.00 |
| Revenue This Year | N/A | $3.20 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ $9.18 | $181.00 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $13.91 | $5.43 |
| 52 Week High | $17.90 | $11.04 |
| Indicator | SWKH | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 32.19 | 48.46 |
| Support Level | $14.69 | $8.49 |
| Resistance Level | $17.08 | $9.97 |
| Average True Range (ATR) | 0.37 | 0.39 |
| MACD | -0.05 | 0.01 |
| Stochastic Oscillator | 12.06 | 27.40 |
SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.